Tokyo, Japan

Yoshio Shu


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tokyo, JP (1993 - 1995)
  • Tokushima, JP (1996)

Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yoshio Shu

Introduction

Yoshio Shu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on carbostyril derivatives. With a total of 3 patents, his inventions have the potential to impact various medical treatments.

Latest Patents

One of Yoshio Shu's latest patents focuses on a novel carbostyril derivative. This derivative is characterized by its excellent platelet aggregation inhibitory activity, phosphodiesterase inhibitory activity, and positive ventricular contraction activity. Additionally, it exhibits anti-ulcer, anti-inflammatory, and cerebral blood flow increasing activities. The carbostyril derivative is notable for its low toxicity, particularly concerning cardiovascular conditions, and its ability to be easily absorbed by the intestinal tract. This makes it a promising candidate for treating thrombi, improving cerebral circulation, and serving as an anti-inflammatory and cardiotonic agent.

Career Highlights

Yoshio Shu is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential applications in treating serious medical conditions.

Collaborations

Yoshio has collaborated with notable coworkers such as Takao Nishi and Katsumi Tamura, contributing to the advancement of their shared research goals.

Conclusion

Yoshio Shu's contributions to the field of pharmaceuticals through his innovative carbostyril derivatives highlight his role as a significant inventor. His work not only showcases his expertise but also holds promise for future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…